Web Content Display Web Content Display

$detailPageBanner.getData()
Maximizing the Potential of Your Product
Header Arrow

Web Content Display Web Content Display

02
Capabilities
Partnering

Web Content Display Web Content Display

Market Opportunities

Menarini Asia-Pacific operates in the fastest growing healthcare markets worldwide, growing at an compounded annual growth rate of 17 percent over the past 3 years, approximately twice the global pharmaceutical market growth. Today, the total Asia-Pacific Pharmaceutical markets represent approximately USD172 billion* and 15.04 percent* of worldwide pharmaceutical sales.

Core Competencies

Menarini Asia-Pacific has instituted proprietary Marketing and Sales processes to launch and optimize brands across the region. The rigorous, data-driven approach to Marketing leverages on proven analytical tools to make the right strategic choices. The unique Sales model is tightly integrated with Marketing and is customized for the Asia-Pacific markets.

Menarini Asia-Pacific also utilizes a proprietary Launch Playbook to ensure full cross-functional readiness well in advance of a product launch in areas such as regulatory status optimization, physician advocacy development, PR, medical publication planning, consumer activation, trade marketing, and supply chain / channel strategy.

Medical and Regulatory

Menarini Asia-Pacific has successfully submitted over 200 New Chemical Entities (NCEs) since 2006 and holds over 1,000 licenses. With over 50 experienced Regulatory professionals across the region and an ever expanding network of Key Opinion Leaders, these have enabled an efficacious pre-marketing execution. Menarini Asia-Pacific's Medical, Clinical Operation and Pharmacovigilance capabilities are well-established, able to deliver high quality medical support, ICH** GCP*** compliant clinical studies and round the clock safety surveillance in accordance with EU guidelines.

Therapeutic Expertise

Menarini Asia-Pacific operates effectively across a broad range of therapeutic areas:

Menarini Asia Pacific Standard Of Business Conduct
Consumer Health
Menarini Asia Pacific Standard Of Business Conduct
Dermatology
Menarini Asia Pacific Standard Of Business Conduct
Select Specialty Care
Menarini Asia Pacific Standard Of Business Conduct
Men's Health
Menarini Asia Pacific Standard Of Business Conduct
Cardiovascular
Menarini Asia Pacific Standard Of Business Conduct
Allergy / Respiratory
Menarini Asia Pacific Standard Of Business Conduct
Gastroenterology

 

*IMS Health 3Q2015
**International Conference on Harmonisation
***Good Clinical Practice

Web Content Display Web Content Display

Web Content Display Web Content Display

FEATURED ARTICLE
FEATURED ARTICLE
Moberg Pharma and Menarini Extend Distribution Agreement for Kersal Nail to South East Asia

Singapore, 6 November 2013 – Menarini Asia-Pacific, a member of the world's largest Italian biopharmaceutical company, officially inaugurated the establishment of Menarini (China) Investment Co. Ltd. and the opening of its national headquarters on 29 October 2013 at the Wuhan National Bioindustry Base ("Wuhan Biolake") in Hubei Province, China.

Web Content Display Web Content Display

FEATURED BRANDS
Side Panel Logo Side Panel Logo Side Panel Logo Side Panel Logo Side Panel Logo Side Panel Logo